Sigvards Krongorns’ Post

Healthcare needs innovation, but the gap between cutting-edge solutions and real-world application remains. Join our HealthTech meetup to explore the latest trends and bridge the gap! ➡️ Keynote: Verge HealthTech Fund unpacks Q1'24 trends & fundraising environment. ➡️ Panel Discussion: Experts tackle the challenges & opportunities of bringing innovation to life.

📢 Portfolio Highlights: Endiatx amazes the audience with a live demonstration of their PillBot at MARS 2024!  The company's co-founder and chairman, Alex Luebke, presented Endiatx's goal of creating a wireless robot guided inside the human body under its own power trasmitting live video in real-time, and walked through the many challenges they had to overcome and the many prototypes they went through to make this goal a reality. At MARS, they demonstrated their success with the PillBot, a capsule-sized deviced that can be swallowed to remotely perform a stomach endoscopy. 💊 The highlight of the presentation was a live demonstration of PillBot: Alex swallowed it on-stage, and the device was piloted by Vivek Kumbhari MD PhD, Head of Gastroenterology at the Mayo Clinic using a handy game controller to perform a live endoscopy in high-definition 🎮 Watch and see PillBot in action here 👉 https://lnkd.in/gFwc_U6n Alex ends the presentation with the many exciting technologies that can build on top of Endiatx's innovation, such as #AI tools for micro-robotics and nano-robots for surgery! 🤖 We can't wait to see the future of healthcare and diagnostics Alex described, like exploring other parts of the body, infrared sensors, lab-on-chips, and pill surgeons. Congratulations Alex, Vivek, Torrey Smith, Christopher Green, Quentin C., and the whole Endiatx team for an illuminating presentation! #HealthTechInnovation #microrobotics #engineering #nanotechnology #healthcare #endoscopy #healthcareinnovation #MARS2024

🧠 Why We Invested in Sooma Medical: revolutionizing depression treatment with an at-home neuromodulation therapy using Transcranial Direct Current Stimulation (tDCS). Depression affects millions globally, yet treatment options remain limited with many suffering from unwanted side effects. But Sooma Medical is changing that by paving the way for neuromodulation therapy with its innovative approach to mental health care: ✅ Innovative Therapy: Sooma's non-invasive tDCS therapy promises side-effect-free treatment for depression and chronic pain, achieving a 60% response rate with excellent treatment adherence. ✅ Clinical Validation: Backed by multiple clinical studies, including 13 randomized controlled trials (RCTs) and 14 open-label studies, with close to 97% of patients showing improvement in depression scores. ✅ Clinical Guidelines: tDCS treatment for depression has been found to be definitely effective, reaching Level A classification, based on systematic reviews and meta-analyses indicating significant therapeutic effect and tolerability. Learn more about our investment in Sooma Medical, a glimpse into the state of mental health care, and how their groundbreaking technology aims to change that: https://lnkd.in/dEMZ7PJH We're passionate about supporting innovative solutions that make a positive impact like Sooma. We're constantly on the lookout for groundbreaking companies that are pushing the boundaries of health technology and narrowing the health equity gap. Connect with us if you feel the same. 🤝 #HealthTech #MentalHealth #Innovation #Investment #mentalhealthawareness #depression #medicaldevices #startupfunding

🚨Investment announcement: We're proud to announce the newest addition to Verge HealthTech Fund's portfolio - Sooma Medical! Based in Finland, Sooma aims to revolutionize how we treat psychiatric and neurological disorders with its clinically-proven medical device. Designed to be portable enough to be used in the comfort of your own home, Sooma's product is an innovative, drug-free treatment that escapes the limitations of existing treatment options for depression such as unwanted side effects for patients. The device is paired with a digital platform that allow clinicians to monitor treatment adherence and tailor treatments for their patients, regardless of their location. Sooma raised €5 million to further develop its neuromodulation devices and its connected digital platform, and accelerate its expansion into new and existing markets, fulfilling its mission of making depression therapies widely available and accessible. Sooma already has regulatory approval to sell its devices in Europe, as well as customers in countries like Australia and Mexico. Highlights from Sooma's journey so far: 🌟 Sooma's portable medical device utilizes Transcranial Direct Current Stimulation (tDCS), enabling a safe and effective at-home depression treatment minus the common side effects of antidepressant medications. It’s designed to be easily accessible to those underserved by medication or with limited access to psychotherapy. 🌟 In just a few years, Sooma's devices have become the most prescribed tDCS therapy globally, having treated 20,000 patients battling depression — a leading cause of disability in the world affecting ~300 million sufferers according to WHO. 🌟 Sooma recently received an FDA Breakthrough Device Designation, reserved only for novel therapies that show significant potential to provide a substantial improvement over existing options for severe or life-threatening conditions, like depression. We are proud to join forces with Voima Ventures, a Nordic early-stage investor, and Stephen Industries, a Helsinki-based family office investing in health technology solutions, in supporting Sooma's mission towards improving worldwide access to effective psychiatric and neurological treatment. We believe in Sooma's vision of providing new hope for all who face debilitating mental health challenges. Read more here 👉https://lnkd.in/gNTd35tV Congratulations and welcome to the Verge community Tuomas Neuvonen and the rest of the Sooma team! #Healthtech #Investment #MentalHealthAwareness #Innovation #ImpactInvesting #HealthcAreaccess #Depression #StartupFunding #MedicalDevices